Sweden Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Sweden Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Sweden Neurology Devices Market is expected to grow with a CAGR of 4.5% during the forecasted period. The key factors propelling the growth of this market are increase in incidence of neurological disorders,huge investments by private players in neurology devices and increase in R&D in the field of neurotherapies.

According to the World Population Ageing 2019 report, in South Africa population aged 65 years or over in 2019 was 2.027 million (20.2%) and this number is projected to reach to 2.355 million (22.2%) in 2030. As number of geriatric population is expected to increase in coming years who are more prone to disorders such as cognitive impairment and dementia which ultimately rises the growth of market in near future.

Thus, owing to above factors the market is expected to show significant growth over the forecast period.

Key Market TrendsSacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period

The sacral nerve stimulation devices are mostly used for patients for whom drug therapy or other types of medications are not successful. It is performed with the help of a small device, which is capable of sending electrical impulses to the targeted sacral nerves located in the lower back region. These devices are found to be successful in treating bladder problems. Hence, with increasing incidences of overactive bladder, the sacral nerve stimulation devices segment is expected to grow during the forecast period.

Sacral nerve stimulation devices are an effective and safe treatment for patients suffering from fecal and urinary dysfunction. Increasing demand for the minimal invasive therapy, rising prevalence of urinary bladder diseases, and technological advancements such as introduction of novel coatings and engineering strategies are the main factors driving the growth of the market.

In sweden, Medtronic Plc offers The InterStim II is an implantable neurostimulator that gently stimulates the sacral nerve, which is thought to normalize neural communication between the bladder and brain and between the bowel and brain. It is used in overactive bladder (OAB), non-obstructive urinary retention, and chronic fecal incontinence conditions.

Thus, owing to above factors the segment is expected to show significant growth over the forecast period.

Competitive Landscape

The Sweden Neurology Devices Market is fragmented competitive. There are market participants involved in R&D for the development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, many private companies are showing great interest in developing novel neurological devices to earn huge profits. In the coming years few other players are expected to enter into the market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

IBM Corporation
Oracle Corporation
Internap Corporation
Packet Inc. (An Equinix Inc. Company)
Scaleway Inc.
Amazon Web Services Inc
Rackspace Inc.
CenturyLink, Inc.
LightEdge Solutions, Inc

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.